“As a doctor and diagnostics entrepreneur, it has been my lifelong dream to provide patients with an optimal treatment designed to meet their individual needs”, explains Prof. Dirk Roggenbuck, the consortium spokesman of PARMENIDes - Initiative for Personalised Diagnostics and Medicine, a project funded by the Federal Ministry of Education and Research (BMBF) to the tune of (a maximum of) one million Euros.
“Unfortunately, research and development in the past increasingly bypassed patients”, Roggenbuck states with regret. “The focus was on quantity and generally applicable guidelines instead on individual needs. The consequence: this “mass therapy” did not reach about 30 percent of patients. PARMENIDes intends to close this gap and take advantage of the key feature of individualized diagnostics to realize the vision of “no therapy without benefit” - managed by the Berlin-Brandenburg Diagnostics Network.
In this BMBF-funded initiative, small and medium-sized diagnostics companies have joined forces with research institutes, laboratories and doctors from different specialist fields as well as patient representatives to promote product developments. Cost bearers and service providers, in particular, have also become involved. In parallel to this, the project also envisages the concept of a Master of Science study course in “Laboratory Diagnostics” at the Brandenburg University of Technology in Cottbus-Senftenberg.
no news in this list.